rethinkTHC Search
Menu
Study breakdown

First placebo-controlled trial of smoked cannabis for PTSD found no treatment outperformed placebo

Randomized Controlled TrialModerate evidence
The takeaway

In the first randomized placebo-controlled trial of smoked cannabis for PTSD in veterans, all groups improved significantly but none of the three active cannabis preparations outperformed placebo.

Veterans considering cannabis for PTSD, PTSD researchers, clinicians advising patients about cannabis for trauma symptoms

No active cannabis preparation outperformed placebo for PTSD symptoms

What the researchers found

Three cannabis preparations (high THC, high CBD, and balanced THC+CBD) were all well tolerated and all groups showed significant PTSD symptom improvement, but no active treatment was statistically better than placebo after three weeks of use.

Why it matters

Despite widespread veteran use of cannabis for PTSD, this first rigorous trial found no evidence that smoked cannabis outperforms placebo. The strong placebo response complicates future trial design.

The numbers in context

80 participants in Stage 1; 74 in Stage 2; high THC (~12% THC, <0.05% CBD); high CBD (11% CBD, 0.50% THC); THC+CBD (~7.9% THC, 8.1% CBD); placebo (<0.03% THC)

How the study worked

Double-blind, cross-over design with 80 veterans randomized to three weeks of active treatment or placebo in Stage 1, then re-randomized to a different active treatment in Stage 2 after a 2-week washout. Primary outcome was change in PTSD symptom severity.

What this study cannot tell us

Brief 3-week treatment period, difficulty blinding smoked cannabis (participants may detect active vs placebo), relatively small sample, cross-over design may introduce carryover effects.

How to read the evidence

Randomized placebo-controlled crossover trial, though limited by small size and short duration

When this study was published

Published in 2021. This landmark trial established that rigorous cannabis-for-PTSD research is feasible.

The bigger picture

The strong placebo response across all groups raises questions about whether expectation effects drive much of the reported benefit of cannabis for PTSD, a finding with implications for both research design and clinical practice.

Questions still open

  • Would longer treatment periods show different results? Can smoked cannabis trials ever be adequately blinded? Would different cannabis formulations or delivery methods show superiority over placebo?

Common questions

Does smoked cannabis help PTSD?
In this first placebo-controlled trial, all groups (including placebo) showed significant PTSD improvement, but no cannabis preparation was statistically better than placebo after three weeks.
Were different cannabis types tested?
Yes. High-THC, high-CBD, and balanced THC/CBD preparations were all tested against placebo. None outperformed placebo, though all were well tolerated.

Read the original research

The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial.

PloS one, 16(3), e0246990

Citation

Bonn-Miller, Marcel O; Sisley, Sue; Riggs, Paula; Yazar-Klosinski, Berra; Wang, Julie B; Loflin, Mallory J E; Shechet, Benjamin; Hennigan, Colin; Matthews, Rebecca; Emerson, Amy; Doblin, Rick. (2021). The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial.. PloS one, 16(3), e0246990. https://doi.org/10.1371/journal.pone.0246990

Explore the wider topic